Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Solomon

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Asia-Pacific Journal of Clinical Oncology|February 10, 2021
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemicKoen Degeling, Nancy N Baxter, Jon Emery, et al.
Cancers|April 27, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint InhibitorsLuke S McLean, Annette M Lim, Christopher Angel, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastomaJames R Whittle, Jason D Lickliter, Hui K Gan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive DiseaseSai-Hong I Ou, Benjamin J Solomon, Alice T Shaw, et al.
Head & Neck|September 3, 2025
Examining CD103<sup>+</sup> Tissue-Resident Memory T Cells in Nasopharyngeal CarcinomaAlesha A Thai, Richard J Young, Mathias Bressel, et al.
The British Journal of Dermatology|July 20, 2023
Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinomaAlesha A Thai, Richard J Young, Mathias Bressel, et al.
Oral Oncology|January 23, 2024
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancerRichard J Young, Christopher Angel, Mathias Bressel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular GenotypingIbiayi Dagogo-Jack, Justin F Gainor, Rebecca L Porter, et al.
Internal Medicine Journal|February 19, 2024
Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programmeMarliese Alexander, Jennifer Rogers, Sagun Parakh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I StudyPasi A Jänne, Alice T Shaw, D Ross Camidge, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Asia-Pacific Journal of Clinical Oncology|February 10, 2021
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemicKoen Degeling, Nancy N Baxter, Jon Emery, et al.
Cancers|April 27, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint InhibitorsLuke S McLean, Annette M Lim, Christopher Angel, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 18, 2015
First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastomaJames R Whittle, Jason D Lickliter, Hui K Gan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2022
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive DiseaseSai-Hong I Ou, Benjamin J Solomon, Alice T Shaw, et al.
Head & Neck|September 3, 2025
Examining CD103<sup>+</sup> Tissue-Resident Memory T Cells in Nasopharyngeal CarcinomaAlesha A Thai, Richard J Young, Mathias Bressel, et al.
The British Journal of Dermatology|July 20, 2023
Comprehensive profiling identifies tumour and immune microenvironmental differences in clinical subsets of cutaneous squamous cell carcinomaAlesha A Thai, Richard J Young, Mathias Bressel, et al.
Oral Oncology|January 23, 2024
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancerRichard J Young, Christopher Angel, Mathias Bressel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2016
Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular GenotypingIbiayi Dagogo-Jack, Justin F Gainor, Rebecca L Porter, et al.
Internal Medicine Journal|February 19, 2024
Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programmeMarliese Alexander, Jennifer Rogers, Sagun Parakh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I StudyPasi A Jänne, Alice T Shaw, D Ross Camidge, et al.
Pageof 13